phenobarbital will minimize the extent or effect of stiripentol by influencing hepatic enzyme CYP1A2 metabolism. Steer clear of or Use Alternate Drug. If unable to avoid coadministration of stiripentol with sturdy CYP1A2 inducers, enhance stiripentol dose.Upon initiation or discontinuation of secukinumab in sufferers that are receiving concomitant